Cargando…
5613423 TREATMENT OF ERYTHROID PRECURSOR CELLS FROM β-THALASSEMIC PATIENTS WITH ISOXAZOLE DERIVATIVES: POTENT INDUCTION OF FETAL HEMOGLOBIN
Autores principales: | Cristina Zuccato, C.Z., Lucia Carmela Cosenza, L.C.C., Gianni Sacchetti, G.S., Riccardo Rondanin, R.R., Daniele Simoni, D.S., Marco Prosdocimi, M.P., Lipucci di Paola, M.L.P., Alessia Finotti, A.F., Roberto Gambari, R.G., Ilaria Lampronti, I.L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112597/ http://dx.doi.org/10.1097/01.HS9.0000928252.78758.54 |
Ejemplares similares
-
5613417 CO-TREATMENT OF ERYTHROID CELLS ISOLATED FROM Β039-THALASSEMIA PATIENTS WITH CRISPR-CAS9 GENE EDITING AND FETAL HEMOGLOBIN INDUCTION
por: Lipucci di Paola, M.L.P., et al.
Publicado: (2023) -
5613398 A DRUG REPOSITIONING PROJECT FOR Β-THALASSEMIA: SIROLIMUS AND CINCHONA ALKALOIDS
por: Michele Lipucci Di Paola, M.L.P., et al.
Publicado: (2023) -
Pro-apoptotic activity of novel synthetic isoxazole derivatives exhibiting inhibitory activity against tumor cell growth in vitro
por: Lampronti, Ilaria, et al.
Publicado: (2020) -
A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs
por: Prosdocimi, Marco, et al.
Publicado: (2022) -
Treatment of Erythroid Precursor Cells from β-Thalassemia Patients with Cinchona Alkaloids: Induction of Fetal Hemoglobin Production
por: Zuccato, Cristina, et al.
Publicado: (2021)